These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6539165)

  • 21. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
    Wondergem J; Bulger RE; Strebel FR; Newman RA; Travis EL; Stephens LC; Bull JM
    Cancer Res; 1988 Jan; 48(2):440-6. PubMed ID: 3335012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
    Roberts JJ; Friedlos F
    Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
    Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of selenite on the toxicity of cis-DDP in mice: estimation of trace elements.
    Shenberg C; Izak-Biran T; Mantel M; Rachmiel B; Weininger J; Chaitchik S
    J Trace Elem Electrolytes Health Dis; 1989 Jun; 3(2):71-5. PubMed ID: 2562498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin.
    Dorie MJ; Brown JM
    Cancer Res; 1993 Oct; 53(19):4633-6. PubMed ID: 8402639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic chemotherapy with super-high dose cisplatin and sodium thiosulfate (STS) rescue in mice].
    Lee K; Sawamura M; Kubota T; Ishibashi N; Kawamura E
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):875-9. PubMed ID: 4039124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia.
    Fulco RA; Vannozzi M; Collecchi P; Merlo F; Parodi B; Civalleri D; Esposito M
    Anticancer Res; 1990; 10(6):1603-10. PubMed ID: 2285232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
    Kurihara N; Kumai K; Kubota T; Furukawa T; Yamamoto T; Shimada A; Shibata S; Saikawa Y; Ogawa S; Murayama Y
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1645-8. PubMed ID: 8373238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
    Eder JP; Teicher BA; Holden SA; Cathcart KN; Schnipper LE; Frei E
    Cancer Res; 1989 Feb; 49(3):595-8. PubMed ID: 2910481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of the bone marrow toxicity of cis-diamminedichloroplatinum(II) in mice by diethyldithiocarbamate.
    Evans RG; Wheatley C; Engel C; Nielsen J; Ciborowski LJ
    Cancer Res; 1984 Sep; 44(9):3686-90. PubMed ID: 6331656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation, characterization, therapeutic efficacy and toxicity of liposomes, containing the antitumour drug cis-dichlorodiamineplatinum(II).
    Reszka R; Fichtner I; Nissen E; Arndt D; Ladhoff AM
    J Microencapsul; 1987; 4(3):201-12. PubMed ID: 3504505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
    Murray D; Jenkins WT; Meyn RE
    Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. I: On the effects of intravesical instillation of cis-diamminedichloroplatinum in normal beagle dogs].
    Hirao Y; Iwai A; Yoshie T; Moriya A; Matsuki H; Yoshida K; Sanma S; Kubota K; Ohara S; Babaya K
    Hinyokika Kiyo; 1985 Jan; 31(1):31-8. PubMed ID: 4039525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumour activity of cis-diamminedichloroplatinum (II) against human tumour xenografts depends on its area under the curve in nude mice.
    Kurihara N; Kubota T; Hoshiya Y; Otani Y; Watanabe M; Kumai K; Kitajima M
    J Surg Oncol; 1996 Feb; 61(2):138-42. PubMed ID: 8606546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
    Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
    Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citrate enhances the protective effect of orally administered bismuth subnitrate against the nephrotoxicity of cis-diamminedichloroplatinum.
    Kondo Y; Himeno S; Satoh M; Naganuma A; Nishimura T; Imura N
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):33-8. PubMed ID: 14530870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432].
    Komatsu K; Nakamura W
    C R Seances Soc Biol Fil; 1986; 180(1):117-20. PubMed ID: 2943364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selenium efficiently depressed toxic side effect of cis-diamminedichloroplatinum.
    Naganuma A; Satoh M; Yokoyama M; Imura N
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):127-34. PubMed ID: 6685904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.